8A96
 
 | SARS Cov2 Spike RBD in complex with Fab47 | Descriptor: | Fab47 Heavy chain (variable domain), Fab47 Light chain (variable domain), Spike protein S1 | Authors: | Hallberg, B.M, Das, H. | Deposit date: | 2022-06-27 | Release date: | 2023-05-03 | Last modified: | 2024-11-13 | Method: | ELECTRON MICROSCOPY (2.7 Å) | Cite: | Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies. Immunity, 56, 2023
|
|
8A99
 
 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Fab47 (Heavy chain variable domain), ... | Authors: | Hallberg, B.M, Das, H. | Deposit date: | 2022-06-28 | Release date: | 2023-05-10 | Last modified: | 2024-10-16 | Method: | ELECTRON MICROSCOPY (2.5 Å) | Cite: | Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies. Immunity, 56, 2023
|
|
8A94
 
 | SARS CoV2 Spike in the 2-up state in complex with Fab47. | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Fab47 (Heavy chain Variable domain), ... | Authors: | Hallberg, B.M, Das, H. | Deposit date: | 2022-06-27 | Release date: | 2023-05-03 | Last modified: | 2024-11-20 | Method: | ELECTRON MICROSCOPY (2.4 Å) | Cite: | Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies. Immunity, 56, 2023
|
|
8A95
 
 | SARS Cov2 Spike RBD in complex with Fab47 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Fab47 (Heavy chain variable domain), ... | Authors: | Hallberg, B.M, Das, H. | Deposit date: | 2022-06-27 | Release date: | 2023-08-16 | Last modified: | 2024-10-23 | Method: | ELECTRON MICROSCOPY (2.64 Å) | Cite: | Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies. Immunity, 56, 2023
|
|